BCRs Flashcards

1
Q

where is BCR located?

A

B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is BCR composed of?

A
  • two identical heavy chains
  • two identical light chains
  • held together by disulphide bridges
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what forms antigen-binding site?

A

variable regions of the heavy and light chains which allows the BCR to recognise specific antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what role does BCR play?

A

in adaptive immunity by allowing B cells to recognise a wide range of antigens and mount an effective immune response against them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what happens when an antigen binds to the BCR?

A

triggers a seris of intracellular signalling events that activate the B cell resulting in proliferation, differentiation into antibody-sescreting plasma cells and the generation of memory B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does proliferation of B cells within the germinal centre lead to ?

A
  • isotope switching of the antibodies from IGM and to IGG, IGA etc
  • drive of affinity maturation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the two forms of BCR

A

1- Signalling receptor
2- Antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe structure of membrane bound form of BCR

A
  • hydrophobic residues at the carboxyl terminus of the heavy chain to anchor the BCR into plasma membrane

made of three sequentially arranged regions:
- extracellular hydrophillic region (spacer region about 26 AA)
- hydrophobic transmembrane segment (25 AA)
- short cytoplasmic tail inside of that membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

whats the difference in structure between membrane bound BCR and soluble circulating BCR (antibodies)

A

the hydrophobic residues in the membrane bound are exchanged for more hydrophillic AA so they can be soluble and circulate throughout the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe structure of membrane bound BCR further

A
  • membrane-bound immunoglobulin non-covalently linked to a heterodimer composed of IGa and IGb
  • this is in toa 1:1 stochiometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does the IGa and IGb heterodimer responsible for?

A

transducing the antigen signal once bound from the outside to the inside of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe IGa and IGb structure

A
  • short n terminal Ig like domains at the top
  • long cytoplasmic tail which contain immuno-receptor tyrosine based activation motifs (ITAMs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what happens when antigen binds to BCR?

A

induces phosphorylation of ITAMs which results in the triggering of signalling cascades (CD79)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Whats another name for IGa and IGb heterodimer?

A

CD79

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What phosphorylayes CD79?

A

LYN (Kinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the signalling cascade caused once CD79 is phosphorylated?

A
  • CD79 phosphorylated by LYn cayses activation of other sites and kinases and signalling peptides such as BLINK, phospholipase C and BTK. forming a signalosome
  • phospholipase C releases DAG which triggers RAS pathway and another pathway
  • PPC also releases IP3 whihc can then activate Ca NFAT pathway
  • leading to activation of B cell
17
Q

describe all IgX

A

IgG- membrane bound and secreted
IgM - membrane bound and secreted as a pentameter
IgD- mainly acts as a receptor
IgA - membrane bound and secreted as a dimer
IgE - membrane bound and secreted

18
Q

what is the antigen bindingsite made up of?

A
  • 6 CDRs that protrude from the V domains
  • CDRs are most variable regions of BCR responsible for specificity of antigen binding
  • CDR1 and CDR2 short and located at N-terminal end of variable domamins
  • CD3 is longest and most diverse
19
Q

name all the moleculat interactions between CDRs and antigens?

A
  • electrostatic
  • hydrogen bonds
  • van der waals
  • hydrophobic interactions
  • cation-pi interactions
20
Q

what is the origin of cation-pi interactions?

A

non-covalent interaction between a cation and an electron cloud of a nearby aromatic group

21
Q

what four things contribute to the specificity of CDRs?

A

1) AA sequence
2) Structural conformation - flexibility
3) Structural conformation - binding pockets
4) Affinity

22
Q

how is AA sequence of CDRs generated?

A

through somatic recombination and somatic hypermutation - allowing for a wide range of possible amino acid sequences and a corresponding diversity of potential antigen binding sites

23
Q

which CDR has the most number of contacts with the antigen?

24
Q

What three key things are important in flexibility of BCRs?

A

1) Adaptation to antigen shape
2) High specificity
3) High affinity

25
name difference between binding pockets when: A) Proteins B) Peptides C) Haptens
A) Plateau's (flat surfacae)~ 800A B) Grooves ~ 400-600A C) Pockets ~ 200-400A
26
what does low Kd mean?
high affinity antibody
27
what is affinity determined by?
number and strength of bonds and surface shape and size
28
what is avidity?
overall strength of binding
29
what is SPR?
surface plasmon resonance
30
what are 4 ways to improve antibody affinity?
1) Affinity maturation 2) site directed mutagenesis 3) protein display systems (phage, ribosome, yeast) 4) protein engineering
31
what are 4 applications for the study of antigen recognition?
1) design of vaccines 2) development of therpeutics 3) understanding immune system function 4) engineering improved antibodies
32
what is site directed mutagenesis?
this involves making specific changes to the antibody's amino acid sequence to optimise its interaction with the target antigen
33
what is protein engineering?
this involves using computational methods to design new antibody variants with improved affinity for the target antigen